Moderna: Pioneering Groundbreaking mRNA Technology
Moderna is the leader in messenger ribonucleic acid (mRNA) technology. mRNA medicines carry genetic blueprints to ribosomes in cells to produce therapeutic proteins and antigens that help the immune system fight diseases and prevent infections. Moderna can tailor entire mRNAs using its Sequence Designer module. This opens the door for the rapid development of personalized medicine and the flexibility to target specific diseases.
The pandemic helped Moderna demonstrate the effectiveness, speed of development, and potential of its mRNA technology after it proved successful with its COVID-19 vaccine. The company has a robust pipeline of mRNA-based candidates targeting infectious diseases, cancer, genetic disorders, and cardiovascular diseases. It's also invested in building scalable manufacturing capabilities that enable it to produce huge quantities of mRNA-based products.